| 19331321
|
Conformation of receptor adopted upon interaction with virus revealed by site-specific fluorescence quenchers and FRET analysis. |
J Am Chem Soc |
2009 |
Wruss J;Pollheimer PD;Meindl I;Reichel A;Schulze K;Schofberger W;Piehler J;Tampe R;Blaas D;Gruber HJ |
View
More |
| 21408223
|
Engineered picornavirus VPg-RNA substrates: analysis of a tyrosyl-RNA phosphodiesterase activity. |
PLoS One |
2011 |
Rozovics JM;Virgen-Slane R;Semler BL |
View
More |
| 23663261
|
mHCN4 genetically modified canine mesenchymal stem cells provide biological pacemaking function in complete dogs with atrioventricular block. |
Pacing Clin Electrophysiol |
2013 |
Lu W;Yaoming N;Boli R;Jun C;Changhai Z;Yang Z;Zhiyuan S |
View
More |
| 23667424
|
Structures of coxsackievirus, rhinovirus, and poliovirus polymerase elongation complexes solved by engineering RNA mediated crystal contacts. |
PLoS One |
2013 |
Gong P;Kortus MG;Nix JC;Davis RE;Peersen OB |
View
More |
| 25261314
|
Reverse genetic engineering of the human rhinovirus serotype 16 genome to introduce an antibody-detectable tag. |
Methods Mol Biol |
2015 |
Walker EJ;Jensen LM;Ghildyal R |
View
More |
| 25653446
|
Chimeric rhinoviruses obtained via genetic engineering or artificially induced recombination are viable only if the polyprotein coding sequence derives from the same species. |
J Virol |
2015 |
Schibler M;Piuz I;Hao W;Tapparel C |
View
More |
| 25869880
|
Engineering human rhinovirus serotype-A1 as a vaccine vector. |
Virus Res |
2015 |
Tomusange K;Yu W;Suhrbier A;Wijesundara D;Grubor-Bauk B;Gowans EJ |
View
More |
| 30672366
|
Effect of Genetic Modifications on Physical and Functional Titers of Adenoviral Cancer Gene Therapy Constructs. |
Hum Gene Ther |
2019 |
Heinio C;Sorsa S;Siurala M;Gronberg-Vaha-Koskela S;Havunen R;Haavisto E;Koski A;Hemminki O;Zafar S;Cervera-Carrascon V;Munaro E;Kanerva A;Hemminki A |
View
More |
